This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Elevance Health Inc. shed 3.9% to $384.51 on what proved to be an all-around mediocre trading session for the stock market, with the S&P 500 Index holding mostly steady at 5,842.01 and the Dow Jones Industrial Average remaining mostly unchanged at 41,859.09.
This was the stock's second consecutive day of losses.
Elevance Health Inc. closed 32.2% short of its 52-week high of $567.26, which the company reached on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors, as UnitedHealth Group Inc. fell 2.1% to $296.67, Cigna Group fell 1.4% to $312.68, and Humana Inc. fell 7.58% to $227.14.
Trading volume totaled 2.0 million, compared to the 50-day average of 1.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 22, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.